Rate of Serum Valproate Concentration Monitoring in Patients with Bipolar Disorder Type I at Srinagarind Hospital Outpatient Clinic.

Conclusion: During treatment of BD-I, the rate of serum valproate concentration monitoring was very few. However, when determination was requested, the SVC was within the therapeutic range. In addition, rate of recording of valproate associated adverse effects was very low and the most frequent adverse effect was mild. The reason for monitoring the clinical response was rarely found. Valproate seems to be easily administered. The dosage can be adjusted using only clinical response and adverse effects. Therefore, valproate was effective and safe in treatment of BD-I. PMID: 29952475 [PubMed - in process]
Source: Journal of the Medical Association of Thailand = Chotmaihet thangphaet - Category: General Medicine Tags: J Med Assoc Thai Source Type: research